Troponin criteria for myocardial infarction after percutaneous coronary intervention

Archives of Internal Medicine

Volumn 172, Issue 6, 2012, Pages 502-508

  Novack, Victor ^a,b   Pencina, Michael ^a   Cohen, David J ^c   Kleiman, Neal S ^d   Yen, Chen Hsing ^a   Saucedo, Jorge F ^e   Berger, Peter B ^f   Cutlip, Donald E ^a,g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Soroka Clinical Research Center   (Israel)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f GEISINGER MEDICAL CENTER   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; TROPONIN;

ADULT; ARTICLE; CORONARY STENT; DRUG ELUTING STENT; ELECTIVE SURGERY; ENZYME BLOOD LEVEL; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURGICAL MORTALITY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CREATINE KINASE, MB FORM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; TIME FACTORS; TROPONIN;

EID: 84858981848     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.2275     Document Type: Article

References (23)

1. Lansky AJ, Stone GW. Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ Cardiovasc Interv. 2010;3(6):602-610.
2. Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med. 2011;364(5):453-464.
3. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 2001;103(23):2780-2783. (Pubitemid 32550063)
4. Stone GW, Mehran R, Dangas G, Lansky AJ, Kornowski R, Leon MB. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation. 2001;104(6):642-647. (Pubitemid 32738516)
5. Jeremias A, Baim DS, Ho KK, et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol. 2004;44(6):1210-1214. (Pubitemid 39208875)
6. Bhatt DL, Topol EJ. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation. 2005;112(6):906-923.
7. Cutlip DE, Kuntz RE. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes. Circulation. 2005;112(6):916-922.
8. Thygesen K, Alpert JS, White HD, et al Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634-2653. (Pubitemid 350182388)
9. Cutlip DE, Windecker S, Mehran R, et al Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344-2351. (Pubitemid 46685903)
10. Kini AS, Lee P, Marmur JD, et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol. 2004;93(1):18-23. (Pubitemid 38022028)
11. Cantor WJ, Newby LK, Christenson RH, et al; SYMPHONY and 2nd SYMPHONY Cardiac Markers Substudy Investigators. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol. 2002;39 (11):1738-1744. (Pubitemid 34595282)
12. Prasad A, Singh M, Lerman A, Lennon RJ, Holmes DR Jr, Rihal CS. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol. 2006;48(9):1765-1770. (Pubitemid 44648624)
13. Cavallini C, Verdecchia P, Savonitto S, et al Italian Atherosclerosis, Thrombosis and Vascular Biology and Society for Invasive Cardiology-GISE Investigators. Prognostic value of isolated troponin I elevation after percutaneous coronary intervention. Circ Cardiovasc Interv. 2010;3(5):431-435.
14. Jacob S, Cohen DJ, Massaro J, Niemyski P, Maresh K, Kleiman N; EVENT Investigators. Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era. Am Heart J. 2005;150(5):887-892. (Pubitemid 41607758)
15. Win HK, Caldera AE, Maresh K, et al EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007;297(18):2001-2009. (Pubitemid 46740352)
16. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960; 20(1):37-46.
17. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981.
18. Klein J, Moeschberger M. Survival Analysis: Techniques for Censored and Truncated Data. 2nd ed. New York, NY: Springer-Verlag; 2003.
19. Natarajan MK, Kreatsoulas C, Velianou JL, Mehta SR, Pericak D, Goodhart DM. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. Am J Cardiol. 2004;93(6):750-753. (Pubitemid 38338569)
20. Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR Jr. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv. 2008;1(1):10-19.
21. Lim CC, van Gaal WJ, Testa L, et al. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention. J Am Coll Cardiol. 2011;57(6):653-661.
22. Windecker S, Serruys PW, Wandel S, et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet. 2008; 372(9644):1163-1173.
23. Serruys PW, Silber S, Garg S, et al. Comparison of zotarolimus-eluting and everolimus- eluting coronary stents. N Engl J Med. 2010;363(2):136-146.